Neonatal Fc Receptor Blockers + Eculizumab Aagh Interaction
Moderateinteraction on record
Description
Concomitant use may lower systemic exposures and reduce effectiveness of eculizumab. Closely monitor for reduced effectiveness.
Mechanism
Reduced systemic exposure of eculizumab via FcRn blockade
Source: NLP:eculizumab-aagh